liu.seSearch for publications in DiVA
Change search
Link to record
Permanent link

Direct link
BETA
Ahlstrand, Christer
Publications (8 of 8) Show all publications
Thulin, H., Kreicbergs, U., Onelov, E., Ahlstrand, C., Carringer, M., Holmang, S., . . . Henningsohn, L. (2011). Defecation disturbances after cystectomy for urinary bladder cancer. BJU International, 108(2), 196-203
Open this publication in new window or tab >>Defecation disturbances after cystectomy for urinary bladder cancer
Show others...
2011 (English)In: BJU International, ISSN 1464-4096, E-ISSN 1464-410X, Vol. 108, no 2, p. 196-203Article in journal (Refereed) Published
Abstract [en]

OBJECTIVE To describe and compare long-term defecation disturbances in patients who had undergone a cystectomy due to urinary bladder cancer with non-continent urostomies, continent reservoirs and orthotopic neobladder urinary diversions. PATIENTS AND METHODS During their follow-up we attempted to contact all men and women aged 30-80 years who had undergone cystectomy and urinary diversion at seven Swedish hospitals. During a qualitative phase we identified defecation disturbances as a distressful symptom and included this item in a study-specific questionnaire together with freehand comments. The patients completed the questionnaire at home. Outcome variables were dichotomized and the results are presented as relative risks with 95% confidence interval. RESULTS The questionnaire was returned from 452 (92%) of 491 identified patients. Up to 30% reported problems with the physiological emptying process of stool (bowel movement, sensory rectal function, awareness of need for defecation, motoric rectal and anal function, straining ability). A sense of decreased straining capacity was reported by 20% of the men and women with non-continent urostomy and 14% and 8% of those with continent reservoirs and orthotopic neobladders, respectively. CONCLUSIONS Of the cystectomized individuals 30% reported problems with the physiological emptying process of stool (bowel movement, sensory rectal function, awareness of need for defecation, motoric rectal and anal function, straining ability). Those wanting to improve the situation for bladder cancer survivors may consider communicating before surgery the possibility of stool-emptying problems, and asking about them after surgery.

Place, publisher, year, edition, pages
Blackwell Publishing Ltd, 2011
Keywords
cystectomy; urinary diversion; faecal straining capacity
National Category
Medical and Health Sciences
Identifiers
urn:nbn:se:liu:diva-69821 (URN)10.1111/j.1464-410X.2010.09815.x (DOI)000292328800014 ()
Available from: 2011-08-10 Created: 2011-08-08 Last updated: 2017-12-08
Carlsson, S., Adolfsson, J., Bratt, O., Johansson, J.-E., Ahlstrand, C., Holmberg, E., . . . Hugosson, J. (2009). Nationwide population-based study on 30-day mortality after radical prostatectomy in Sweden. SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 43(5), 350-356
Open this publication in new window or tab >>Nationwide population-based study on 30-day mortality after radical prostatectomy in Sweden
Show others...
2009 (English)In: SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, ISSN 0036-5599, Vol. 43, no 5, p. 350-356Article in journal (Refereed) Published
Abstract [en]

Objective. The incidence of prostate cancer in Sweden is increasing rapidly, as is treatment with curative intent. Radical prostatectomy (RP) is currently commonly performed, either within or outside large high-volume centres. The aim of this study was to assess the 30-day mortality rate after RP in Sweden. Material and methods. In this nationwide population-based study, all men diagnosed with localized prostate cancer (andlt;= 70 years, clinical stadium T1-2, prostate-specific antigen andlt;20 ng/ml) who underwent RP in Sweden between 1997 and 2002 were identified through the National Prostate Cancer Register (NPCR). Mortality within 30 days of RP was analysed through linkage between the follow-up study of the NPCR and the Regional Population Registers. The cause of death in the death certificates were compared with data from the hospitals concerned. To validate the results, a record linkage between the Inpatient Register and the National Population Register was also performed. Results. The number of RPs performed increased over time. Among 3700 RPs performed, four deaths occurred during the first 30 days, yielding a 0.11% 30-day mortality rate. These deaths occurred at three different types of hospital and were all probably related to the RP. Conclusion. This study provides further evidence that RP is a procedure with very low perioperative mortality even when performed outside high-volume centres.

Keywords
30-day mortality, prostatectomy, prostatic neoplasms
National Category
Medical and Health Sciences
Identifiers
urn:nbn:se:liu:diva-52417 (URN)10.3109/00365590902916930 (DOI)
Available from: 2010-01-11 Created: 2009-12-18 Last updated: 2010-01-11
Adolfsson, J., Garmo, H., Varenhorst, E., Ahlgren, G., Ahlstrand, C., Andrén, O., . . . Stattin, P. (2007). Clinical characteristics and primary treatment of prostate cancer in Sweden between 1996 and 2005. Scandinavian Journal of Urology and Nephrology, 41(6), 456-477
Open this publication in new window or tab >>Clinical characteristics and primary treatment of prostate cancer in Sweden between 1996 and 2005
Show others...
2007 (English)In: Scandinavian Journal of Urology and Nephrology, ISSN 0036-5599, E-ISSN 1651-2065, Vol. 41, no 6, p. 456-477Article in journal (Refereed) Published
Abstract [en]

Objective. The incidence of prostate cancer is rising rapidly in Sweden and there is a need to better understand the pattern of diagnosis, tumor characteristics and treatment. Material and methods. Between 1996 and 2005, all new cases of adenocarcinoma of the prostate gland were intended to be registered in the National Prostate Cancer Register (NPCR). This register contains information on diagnosing unit, date of diagnosis, cause of diagnosis, tumor grade, tumor stage according to the TNM classification in force, serum prostate-specific antigen (PSA) levels at diagnosis and primary treatment given within the first 6 months after diagnosis. Results. In total, 72 028 patients were registered, comprising >97% of all pertinent incident cases of prostate cancer in the Swedish Cancer Register (SCR). During the study period there was a considerable decrease in median age at the time of diagnosis, a stage migration towards smaller tumors, a decrease in median serum PSA values at diagnosis, a decrease in the age-standardized incidence rate of men diagnosed with distant metastases or with a PSA level of >100 ng/ml at diagnosis and an increase in the proportion of tumors with Gleason score ≤6. Relatively large geographical differences in the median age at diagnosis and the age-standardized incidence of cases with category T1c tumors were observed. Treatment with curative intent increased dramatically and treatment patterns varied according to geographical region. In men with localized tumors and a PSA level of <20 ng/ml at diagnosis, expectant treatment was more commonly used in those aged ≥75 years than in those aged <75 years. Also, the pattern of endocrine treatment varied in different parts of Sweden. Conclusions. All changes in the register seen over time are consistent with increased diagnostic activity, especially PSA testing, resulting in an increased number of cases with early disease, predominantly tumors in category T1c. The patterns of diagnosis and treatment of prostate cancer vary considerably in different parts of Sweden. The NPCR continues to be an important source for research, epidemiological surveillance of the incidence, diagnosis and treatment of prostate cancer. © 2007 Taylor & Francis.

National Category
Medical and Health Sciences
Identifiers
urn:nbn:se:liu:diva-40493 (URN)10.1080/00365590701673625 (DOI)53376 (Local ID)53376 (Archive number)53376 (OAI)
Available from: 2009-10-10 Created: 2009-10-10 Last updated: 2017-12-13
Henningsohn, L., Wijkstrom, H., Steven, K., Pedersen, J., Ahlstrand, C., Aus, G., . . . Steineck, G. (2003). Relative importance of sources of symptom-induced distress in urinary bladder cancer survivors. European Urology, 43(6), 651-662
Open this publication in new window or tab >>Relative importance of sources of symptom-induced distress in urinary bladder cancer survivors
Show others...
2003 (English)In: European Urology, ISSN 0302-2838, E-ISSN 1873-7560, Vol. 43, no 6, p. 651-662Article in journal (Refereed) Published
Abstract [en]

Objective: The influence of specific symptoms on emotions and social activities in the individual patient vanes. Little is known about this variation in urinary bladder cancer survivors (in other words, about the relative importance of sources of symptom-induced distress). Methods: We attempted to enrol 404 surgical patients treated with cystectomy and a conduit or reservoir in four Swedish towns (Stockholm, Orebro, Jonkoping, Linkoping), 101 surgical patients treated with cystectomy and orthotopic neobladder at the Herlev Hospital in Copenhagen, Denmark, and 71 patients treated with radical radiotherapy for bladder cancer, as well as 581 men and women controls in Stockholm and Copenhagen. An anonymous postal questionnaire was used to collect the information. Results: A total of 503 out of 576 (87%) treated patients and 422 out of 581 (73%) controls participated but 59 patients were excluded. The primary source of self-assessed distress among cystectomised patients was compromised sexual function, reduced intercourse frequency caused great distress in 19% of the conduit patients, 20% of the reservoir patients and 19% of the bladder substitute patients. The primary source of self-assessed distress in patients treated with radical radiotherapy was symptoms from the bowel, 17% reported great distress due to diarrhoea, 16% due to abdominal pain, 14% due to defecation urgency and 14% due to faecal leakage. The highest proportion of subjects being distressed was 93% (substantial: 43%, moderate: 29% and little: 21%) for treated upper or lower urinary retention (indwelling catheter or nephrostomy). Conclusion: The distress caused by a specific symptom varies considerably and the prevalence of symptoms causing great distress differs between treatments in bladder cancer survivors. It is possible that patient care and clinical research can be made more effective by focusing on important sources of symptom-induced distress. (C) 2003 Elsevier Science B.V. All rights reserved.

Keywords
bladder neoplasm, cystectomy, radiotherapy, distressful symptoms, urinary symptoms, bowel symptoms, urinary diversion, bladder substitute
National Category
Medical and Health Sciences
Identifiers
urn:nbn:se:liu:diva-47788 (URN)10.1016/S0302-2838(03)00135-0 (DOI)
Available from: 2009-10-11 Created: 2009-10-11 Last updated: 2017-12-13
Henningsohn, L., Wijkström, H., Pedersen, J., Ahlstrand, C., Aus, G., Bergmark, K., . . . Steineck, G. (2003). Time after surgery, symptoms and well-being in survivors of urinary bladder cancer. BJU International, 91(4), 325-330
Open this publication in new window or tab >>Time after surgery, symptoms and well-being in survivors of urinary bladder cancer
Show others...
2003 (English)In: BJU International, ISSN 1464-4096, E-ISSN 1464-410X, Vol. 91, no 4, p. 325-330Article in journal (Refereed) Published
Abstract [en]

OBJECTIVE: To evaluate how an increasing burden of symptoms influences well-being, anxiety and depression at different intervals after a radical cystectomy with urostomy for bladder cancer, as this therapy can induce long-term distressful symptoms. PATIENTS AND METHODS: Patients with bladder cancer undergoing radical cystectomy in Stockholm between 1969 and 1995 were matched with 434 controls from the normal population, all 404 patients operated on between 1985 and 1995 at three other hospitals in Sweden were invited to enter the study. The final analysis included 306 patients and 310 controls, all assessed for symptoms and well-being. RESULTS: A low or moderate level of well-being was reported by 35% of the patients having none or one of the symptoms studied, by 39% with two symptoms, by 45% with three symptoms and by 66% of those with four or more symptoms. The values, irrespective of symptom burden, were 45% after 2-5 years of follow-up, 58% after 6-10 years and 38% at > 10 years after surgery. The total symptom burden also influenced the risk of anxiety and depression. Symptom prevalence remained largely unaffected by the duration of follow-up, except for defecation urgency. CONCLUSIONS: The number of long-term symptoms after radical surgery with a urostomy for urinary bladder cancer affects the risk of anxiety, depression and low or moderate well-being.

National Category
Medical and Health Sciences
Identifiers
urn:nbn:se:liu:diva-24835 (URN)10.1046/j.1464-410X.2003.04101.x (DOI)9233 (Local ID)9233 (Archive number)9233 (OAI)
Available from: 2009-10-07 Created: 2009-10-07 Last updated: 2017-12-13
Adolfsson, P., Ahlstrand, C., Varenhorst, E. & Svensson, S. (2002). Lysophosphatidic acid stimulates proliferation of cultured smooth muscle cells from human BPH tissue: Sildenafil and papaverin generate inhibition. The Prostate, 51(1), 50-58
Open this publication in new window or tab >>Lysophosphatidic acid stimulates proliferation of cultured smooth muscle cells from human BPH tissue: Sildenafil and papaverin generate inhibition
2002 (English)In: The Prostate, ISSN 0270-4137, E-ISSN 1097-0045, Vol. 51, no 1, p. 50-58Article in journal (Refereed) Published
Abstract [en]

Background The endogenous substance lysophosphatidic acid (LPA) has been found to generate proliferation of cultured smooth muscle cells (SMC). Therefore, the effect of LPA on human benign prostate hyperplasia (BPH) could be of interest.

Methods The proliferative effect of LPA on cultured human prostatic SMC from specimens obtained at trans-urethral resection of the prostate (TURP) because of BPH, was analyzed by [3H]-thymidine and [35S]-methionine incorporation. In addition, LPA stimulated BPH SMC were treated with papaverin, forskolin, sildenafil or zaprinast, well known to increase the intracellular level of cAMP or cGMP.

Results LPA produced a dose-dependent increase in BPH SMC, both regarding DNA- and protein-synthesis with EC50 values of 3 and 10 μM, respectively. Furthermore, both papaverin, a general phosphodiesterase inhibitor regarding cAMP hydrolyzes, and forskolin, an adenylyl cyclase stimulating agent, inhibited the LPA-stimulated DNA replication in a dose dependent manner with IC50  = 2.5, and 0.35 μM, respectively. cGMP increasing agents, such as the NO-donors SIN-1 and SNAP, produced a weak anti-proliferative response. However, both phosphodiesterase 5 inhibitors sildenafil (Viagra®) and zaprinast efficiently blocked DNA replication. In addition, when the protein synthesis was examined, we found that the LPA response was significantly inhibited by forskolin and papaverin.

Conclusions The major conclusion of this investigation is that the endogenous serum component LPA, is able to promote human BPH SMC growth. In addition, our study indicates that cyclic nucleotides can inhibit this effect. Future clinical studies will be needed to determine if different specific phosphodiesterase inhibitors per se or in combination could represent a new therapeutic possibility for the treatment of BPH.

Keywords
BPH, SMC, hyperplastic, PDE, AC, cAMP, cGMP, [H-3]-thymidine, [S-35]-methionine, proliferation
National Category
Medical and Health Sciences
Identifiers
urn:nbn:se:liu:diva-47887 (URN)10.1002/pros.10077 (DOI)
Note
On the day of the defence day the status of this article was submitted.Available from: 2009-10-11 Created: 2009-10-11 Last updated: 2017-12-13Bibliographically approved
Kristjansson, B., Carlsson, P., Ahlstrand, C., Folkestad, B. & Spångberg, A. (1998). Routine measurements of Health Outcome in Management of Patients with Benign Prostatic Hyperplasia (BPH). In: Outcome measuring : "outcome-measures make sense; do they make a difference?". Stockholm: Spri
Open this publication in new window or tab >>Routine measurements of Health Outcome in Management of Patients with Benign Prostatic Hyperplasia (BPH)
Show others...
1998 (English)In: Outcome measuring : "outcome-measures make sense; do they make a difference?", Stockholm: Spri , 1998Chapter in book (Other academic)
Place, publisher, year, edition, pages
Stockholm: Spri, 1998
Series
Spri tryck ; 310
National Category
Social Sciences Interdisciplinary
Identifiers
urn:nbn:se:liu:diva-33514 (URN)19538 (Local ID)19538 (Archive number)19538 (OAI)
Available from: 2009-10-09 Created: 2009-10-09 Last updated: 2018-01-13
Adolfsson, P. I., Ahlstrand, C., Varenhorst, E., Hultgren, S. & Svensson, S. P. S.Characterization of EDG receptor expression and proliferative response in cultured human BPH smooth muscle cells.
Open this publication in new window or tab >>Characterization of EDG receptor expression and proliferative response in cultured human BPH smooth muscle cells
Show others...
(English)Manuscript (preprint) (Other academic)
Abstract [en]

The endogenous phospholipids, lysophosphatidic acid (LPA) and sphingosine 1-phosphate (S1P) are both known to generate a Vvide variety of effects in various cell systems by the endothelial differentiation gene (Edg) receptor family, including 7 different G-protein coupled Edg receptors.

In this study, expression of LPA- and SlP Edg receptors was examined, and so was the effect with respect to proliferation on cultured BPH smooth muscle cells smc. Mmeover, theresponse on cAMP levels was examined. Finally, a potential link between activation of the MAP kinase cascade and the LPA stimulated proliferation was investigated.

First, the RT-PCR analysis of the Edg receptors in BPH smc, demonstrated a heterogeneous expression including all receptors except the Edg6 subtype. Further, in contrast to LPA, the mitogen effect of SIP, demonstrated a concentration-dependent biphasic response, including stimulation below 1μM, whereas inhibition was obtained at higher concentrations. Forskolin induced a rapid and transient cAMP response in LPA stimulated cells, with a peak-value after 3 minutes. After 15 minutes the cAMP level had retmned to base-line level. However a gradual increase to 15% of maximum value was obtained after additional 30 minutes, and thereafter a gradual reduction was observed. The mentioned antiproliferative response generated by SIP could not be conelated to an intracellular cAMP increase. Finally, when the LPA treated smc was co-incubated with the MAPK kinase inhibitor PD98059 (10 μM) the mitogen response was eliminated.

The cAIVIP increase, which was induced by forskolin, corresponds with mentioned antiproliferative effect whereas a similar con-elation was not obtained regarding SIP. The intracellular signal mechanisms triggered by LPA and S1P in BPH smc remain to be further investigated.

National Category
Medical and Health Sciences
Identifiers
urn:nbn:se:liu:diva-80084 (URN)
Available from: 2012-08-20 Created: 2012-08-20 Last updated: 2012-08-20Bibliographically approved
Organisations

Search in DiVA

Show all publications